Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AMRX

Amneal Pharmaceuticals (AMRX)

Amneal Pharmaceuticals Holding Co
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:AMRX
DateTimeSourceHeadlineSymbolCompany
06/09/202406:05Business WireAmneal and Shilpa Announce U.S. FDA Approval of BORUZU™, the First Ready-to-Use Version of Bortezomib for subcutaneous administrationNYSE:AMRXAmneal Pharmaceuticals Holding Co
21/08/202401:26Business WireAmneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose VialsNYSE:AMRXAmneal Pharmaceuticals Holding Co
20/08/202422:00Business WireAmneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose VialsNYSE:AMRXAmneal Pharmaceuticals Holding Co
15/08/202405:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
15/08/202401:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
14/08/202419:56IH Market NewsUBS Beats Earnings Forecasts, Intel Divests Arm Holdings, Flutter Surges 9% in Premarket Trading, and MoreNYSE:AMRXAmneal Pharmaceuticals Holding Co
09/08/202420:05Business WireAmneal Reports Second Quarter 2024 Financial ResultsNYSE:AMRXAmneal Pharmaceuticals Holding Co
08/08/202406:45Business WireAmneal Receives U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease to Be Launched as CREXONT® (Carbidopa and Levodopa) Extended-Release CapsulesNYSE:AMRXAmneal Pharmaceuticals Holding Co
30/07/202406:05Business WireAmneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV BagsNYSE:AMRXAmneal Pharmaceuticals Holding Co
12/07/202406:05Business WireAmneal to Report Second Quarter 2024 Results on August 9, 2024NYSE:AMRXAmneal Pharmaceuticals Holding Co
10/07/202406:05Business WireAmneal Launches FOCINVEZ™, the First Ready-to-Use Version of FosaprepitantNYSE:AMRXAmneal Pharmaceuticals Holding Co
01/07/202422:00Business WireKashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)NYSE:AMRXAmneal Pharmaceuticals Holding Co
01/07/202422:00Business WireAmneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab BiosimilarNYSE:AMRXAmneal Pharmaceuticals Holding Co
28/06/202422:00Business WireAmneal Releases 2023 Environmental, Social and Governance ReportNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/06/202422:00Business WireAmneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New TherapiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
23/05/202406:05Business WireAmneal to Participate at Upcoming Investor ConferenceNYSE:AMRXAmneal Pharmaceuticals Holding Co
23/05/202406:05Business WireAmneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of CaliforniaNYSE:AMRXAmneal Pharmaceuticals Holding Co
17/05/202405:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
17/05/202405:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
15/05/202406:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
15/05/202406:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
15/05/202406:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
15/05/202406:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
08/05/202406:18Edgar (US Regulatory)Form 8-K - Current reportNYSE:AMRXAmneal Pharmaceuticals Holding Co
07/05/202407:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
07/05/202407:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
07/05/202407:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
07/05/202407:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
07/05/202407:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
03/05/202420:14Edgar (US Regulatory)Form 8-K - Current reportNYSE:AMRXAmneal Pharmaceuticals Holding Co
 Showing the most relevant articles for your search:NYSE:AMRX